CCL2 and diabetes mellitus: Recently, QUET was shown to reduce diabetes-induced neuroinflammation by inhibiting astrocyte and microglia activation, as well as by lowering TNF-α and monocyte chemoattractant protein-1 (MCP-1) levels in the mouse hippocampus and cerebrospinal fluid [22].